American Society of Hematology: No Excess Bleeding With Apixaban in Hip, Knee Trial, University of Oklahoma Study

Published: Dec 06, 2010

MedPageToday -- ORLANDO -- In patients undergoing hip or knee replacement surgery, postoperative treatment with the experimental anticoagulant apixaban appeared to prevent venous thromboembolism (VTE) more effectively than treatment with low molecular weight heparin, researchers said here.

Back to news